Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06604442
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-17
Brief Title:
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat 18F and Flotufolastat 18F PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat 18F and Flotufolastat 18F PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat 18F and Flotufolastat 18F PET in Men with Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy
Detailed Description:
This is a multi-center prospective intra-patient comparator study of urinary radioactivity standardized uptake values SUV following both piflufolastat 18F and flotufolastat 18F positron emission tomography PET in patients with low prostate-specific antigen PSA 05 ngmL biochemical recurrence BCR of prostate cancer following radical prostatectomy RP
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None